Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis

This document accompanies the WHO Guidelines on management of Taenia solium neurocysticercosis (WHO, 2021) and is intended for medical practitioners. It focuses on the two anthelminthic medicines used to treat neurocysticercosis: albendazole and praziquantel.